You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • AB0700 Efficacy and drug survival of anti-tumour necrosis factor-alpha therapies in patients with spondyloarthritis: analysis from the thai rheumatic disease prior authorization (RDPA) register

Citation Tools

Article menu

Download PDFPDF

Abstracts Accepted for Publication
Spondyloarthritis - treatment
AB0700 Efficacy and drug survival of anti-tumour necrosis factor-alpha therapies in patients with spondyloarthritis: analysis from the thai rheumatic disease prior authorization (RDPA) register
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Chiowchanwisawakit P, Katchamart W, Chevaisrakul P, et al
AB0700 Efficacy and drug survival of anti-tumour necrosis factor-alpha therapies in patients with spondyloarthritis: analysis from the thai rheumatic disease prior authorization (RDPA) register
Annals of the Rheumatic Diseases 2017;76:1298-1299.